Patrick Burnett - Net Worth and Insider Trading
Patrick Burnett Net Worth
The estimated net worth of Patrick Burnett is at least $2 Million dollars as of 2024-12-29. Patrick Burnett is the See Remarks of Arcutis Biotherapeutics Inc and owns about 128,669 shares of Arcutis Biotherapeutics Inc (ARQT) stock worth over $2 Million. Details can be seen in Patrick Burnett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick Burnett has not made any transactions after 2024-11-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Patrick Burnett
Patrick Burnett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Patrick Burnett owns 2 companies in total, including Arcutis Biotherapeutics Inc (ARQT) , and Verrica Pharmaceuticals Inc (VRCA) .
Click here to see the complete history of Patrick Burnett’s form 4 insider trades.
Insider Ownership Summary of Patrick Burnett
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ARQT | Arcutis Biotherapeutics Inc | 2024-11-22 | See Remarks |
VRCA | Verrica Pharmaceuticals Inc | 2018-06-14 | Chief Medical Officer |
Patrick Burnett Latest Holdings Summary
Patrick Burnett currently owns a total of 1 stock. Patrick Burnett owns 128,669 shares of Arcutis Biotherapeutics Inc (ARQT) as of November 22, 2024, with a value of $2 Million.
Latest Holdings of Patrick Burnett
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ARQT | Arcutis Biotherapeutics Inc | 2024-11-22 | 128,669 | 14.30 | 1,839,967 |
Holding Weightings of Patrick Burnett
Patrick Burnett Form 4 Trading Tracker
According to the SEC Form 4 filings, Patrick Burnett has made a total of 12 transactions in Arcutis Biotherapeutics Inc (ARQT) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Arcutis Biotherapeutics Inc is the sale of 16,023 shares on November 22, 2024, which brought Patrick Burnett around $162,473.
Insider Trading History of Patrick Burnett
- 1
Patrick Burnett Trading Performance
Patrick Burnett Ownership Network
Patrick Burnett Owned Company Details
What does Arcutis Biotherapeutics Inc do?
Who are the key executives at Arcutis Biotherapeutics Inc?
Patrick Burnett is the See Remarks of Arcutis Biotherapeutics Inc. Other key executives at Arcutis Biotherapeutics Inc include director & President and CEO Todd Franklin Watanabe , Chief Commercial Officer Larry Todd Edwards , and SVP and General Counsel Masaru Matsuda .
Arcutis Biotherapeutics Inc (ARQT) Insider Trades Summary
Over the past 18 months, Patrick Burnett made 9 insider transaction in Arcutis Biotherapeutics Inc (ARQT) with a net sale of 204,518. Other recent insider transactions involving Arcutis Biotherapeutics Inc (ARQT) include a net sale of 18,754 shares made by Masaru Matsuda , a net sale of 70,000 shares made by Howard G. Welgus , and a net sale of 68,471 shares made by Todd Franklin Watanabe .
In summary, during the past 3 months, insiders sold 178,763 shares of Arcutis Biotherapeutics Inc (ARQT) in total and bought 12,788 shares, with a net sale of 165,975 shares. During the past 18 months, 413,265 shares of Arcutis Biotherapeutics Inc (ARQT) were sold and 113,840 shares were bought by its insiders, resulting in a net sale of 299,425 shares.
Arcutis Biotherapeutics Inc (ARQT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arcutis Biotherapeutics Inc Insider Transactions
Patrick Burnett Mailing Address
Above is the net worth, insider trading, and ownership report for Patrick Burnett. You might contact Patrick Burnett via mailing address: C/o Verrica Pharmaceuticals Inc., 10 North High Street, Suite 200, West Chester Pa 19380.